• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非裔美国人多发性硬化症的快速病程。

Rapid disease course in African Americans with multiple sclerosis.

机构信息

Department of Neurology, NYU School of Medicine, Multiple Sclerosis Care Center, New York, NY 10003-3804, USA.

出版信息

Neurology. 2010 Jul 20;75(3):217-23. doi: 10.1212/WNL.0b013e3181e8e72a.

DOI:10.1212/WNL.0b013e3181e8e72a
PMID:20644149
Abstract

OBJECTIVE

To investigate utility of a Multiple Sclerosis Severity Scale (MSSS)-based classification system for comparing African American (AA) and white American (WA) multiple sclerosis (MS) subpopulations in the New York State Multiple Sclerosis Consortium (NYSMSC) database. MSSS is a frequency-rank algorithm relating MS disability to disease duration in a large, untreated reference population. Design/

METHODS

Distributions of patients in 6 MSSS-based severity grades were calculated for AA and WA registrants.

RESULTS

There were 419 AA and 5,809 WA patients in the NYSMSC, who had EDSS recorded during years 1-30 since symptom onset. Median EDSS was not different in AA and WA (3.5 vs 3.0, p = 0.60), whereas median MSSS in AA was higher than in WA (6.0 vs 4.8, p = 0.001). AA patients were overrepresented in the 2 most severe grades (41.5% vs 29.3% for WA) and underrepresented in the 2 lowest grades (23.4% vs 35.4%; p < 0.001). In multivariable analysis (ordered logistic and median regression), MSSS for AA remained significantly higher than in WA after adjusting for age, gender, disease duration, disease type distribution, and treatment with disease-modifying therapies.

CONCLUSIONS

The 6-tiered MSSS grading system is a powerful tool for comparing rate of disease progression in subpopulations of interest. MSSS-based analysis demonstrates that African ancestry is a risk factor for a more rapidly disabling disease course.

摘要

目的

研究基于多发性硬化严重程度量表(MSSS)的分类系统在纽约州多发性硬化协会(NYSMSC)数据库中比较非裔美国人和白人美国人多发性硬化亚群的效用。MSSS 是一种频率-等级算法,将 MS 残疾与未经治疗的大参考人群中的疾病持续时间相关联。设计/方法:计算了 6 个 MSSS 严重程度等级中 AA 和 WA 登记患者的分布。结果:NYSMSC 中有 419 名 AA 和 5809 名 WA 患者,他们在发病后 1-30 年内记录了 EDSS。AA 和 WA 的中位 EDSS 无差异(3.5 与 3.0,p=0.60),而 AA 的中位 MSSS 高于 WA(6.0 与 4.8,p=0.001)。AA 患者在 2 个最严重的等级中占比过高(41.5%比 WA 中的 29.3%),在 2 个最低的等级中占比过低(23.4%比 WA 中的 35.4%;p<0.001)。在多变量分析(有序逻辑回归和中位数回归)中,在调整年龄、性别、疾病持续时间、疾病类型分布和疾病修饰疗法治疗后,AA 的 MSSS 仍显著高于 WA。结论:6 级 MSSS 分级系统是比较感兴趣的亚群中疾病进展率的有力工具。基于 MSSS 的分析表明,非洲血统是疾病进展更快导致残疾的危险因素。

相似文献

1
Rapid disease course in African Americans with multiple sclerosis.非裔美国人多发性硬化症的快速病程。
Neurology. 2010 Jul 20;75(3):217-23. doi: 10.1212/WNL.0b013e3181e8e72a.
2
Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans.西班牙裔美国人和非裔美国人多发性硬化症的疾病进程比白种人更为严重。
Mult Scler. 2017 Oct;23(11):1554-1557. doi: 10.1177/1352458516679894. Epub 2016 Nov 29.
3
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium.随着纳入纽约州多发性硬化症联合会的年份的增加,多发性硬化症严重程度评分(MSSS)呈下降趋势。
Mult Scler. 2011 Jun;17(6):725-33. doi: 10.1177/1352458510396269. Epub 2011 Jan 26.
4
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium.纽约州多发性硬化症联盟中非洲裔美国患者的多发性硬化症特征
Mult Scler. 2003 Jun;9(3):293-8. doi: 10.1191/1352458503ms909oa.
5
Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.非裔美国人多发性硬化症患者的组织损伤和病变体积增加。
Neurology. 2010 Feb 16;74(7):538-44. doi: 10.1212/WNL.0b013e3181cff6fb. Epub 2010 Jan 20.
6
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.多发性硬化严重程度评分:利用残疾情况和病程来评估疾病严重程度。
Neurology. 2005 Apr 12;64(7):1144-51. doi: 10.1212/01.WNL.0000156155.19270.F8.
7
Pediatric Multiple Sclerosis Severity Score in a large US cohort.美国一个大型队列中的儿童多发性硬化症严重程度评分
Neurology. 2020 Sep 29;95(13):e1844-e1853. doi: 10.1212/WNL.0000000000010414. Epub 2020 Jul 20.
8
Response to disease modifying therapies in African Americans with multiple sclerosis.多发性硬化症非裔美国人对疾病修正治疗的反应。
Ethn Dis. 2012 Spring;22(2):221-5.
9
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype.重新定义多发性硬化严重程度评分(MSSS):性别和发病表型的影响。
Mult Scler. 2020 Nov;26(13):1765-1774. doi: 10.1177/1352458519881994. Epub 2019 Oct 31.
10
Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review.非裔美国人多发性硬化症的表型与预后:一项回顾性病历审查
Mult Scler. 2006 Dec;12(6):775-81. doi: 10.1177/1352458506070923.

引用本文的文献

1
A Cross-Sectional Study of Delayed Diagnosis Associated with Gender and Racial Identity in Multiple Sclerosis.一项关于多发性硬化症中与性别和种族身份相关的延迟诊断的横断面研究。
J Racial Ethn Health Disparities. 2025 Sep 5. doi: 10.1007/s40615-025-02611-6.
2
Multiple Sclerosis in People of Diverse Racial and Ethnic Backgrounds: Presentation, Disease Course, and Interactions with Disease-Modifying Therapy.不同种族和族裔背景人群中的多发性硬化症:临床表现、疾病进程以及与疾病修正治疗的相互作用
CNS Drugs. 2025 Jul 18. doi: 10.1007/s40263-025-01205-4.
3
Neuroimaging phenotype characterization of early aggressive and late severe multiple sclerosis: a case-control study.
早期侵袭性和晚期重症多发性硬化的神经影像学表型特征:一项病例对照研究。
Brain Commun. 2025 Jun 24;7(4):fcaf254. doi: 10.1093/braincomms/fcaf254. eCollection 2025.
4
Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis.富马酸盐与1-磷酸鞘氨醇受体调节剂对黑人多发性硬化症患者的疗效比较
Neurol Ther. 2025 Jun 16. doi: 10.1007/s40120-025-00774-2.
5
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA.美国使用富马酸盐治疗的黑人、西班牙裔、亚裔和白人多发性硬化症患者的真实世界治疗结果
Neurol Ther. 2025 Jun 16. doi: 10.1007/s40120-025-00773-3.
6
Embodiment of structural racism and multiple sclerosis risk and outcomes in the USA.美国结构性种族主义与多发性硬化症风险及结局的体现
Nat Rev Neurol. 2025 May 27. doi: 10.1038/s41582-025-01096-5.
7
Brain lesion characteristics in Chinese multiple sclerosis patients: A 7-T MRI cohort study.中国多发性硬化症患者的脑病变特征:一项7-T磁共振成像队列研究。
Ann Clin Transl Neurol. 2025 Feb;12(2):300-310. doi: 10.1002/acn3.52256. Epub 2024 Nov 22.
8
The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study.英国的种族与多发性硬化症特征之间的关系:一项英国多发性硬化症登记研究。
Mult Scler. 2024 Oct;30(11-12):1544-1555. doi: 10.1177/13524585241277018. Epub 2024 Sep 20.
9
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT).种族和原籍国收入在多发性硬化症中的作用:意大利多中心研究(MS-MigIT)
J Neurol. 2024 May;271(5):2182-2194. doi: 10.1007/s00415-024-12214-6. Epub 2024 Feb 16.
10
Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States.关于识别和理解美国多发性硬化症患者中服务不足人群的护理障碍的播客。
Neurol Ther. 2024 Feb;13(1):1-9. doi: 10.1007/s40120-023-00559-5. Epub 2023 Nov 20.